Treatment of cataplexy in a three-year-old using venlafaxine

Journal of Clinical Sleep Medicine

Volumn 9, Issue 12, 2013, Pages 1341-1342

  Ratkiewicz, Michelle ^a   Splaingard, Mark ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Cataplexy; Toddler; Venlafaxine

Indexed keywords

HLA DQB1 ANTIGEN; VENLAFAXINE;

ARTICLE; CASE REPORT; CATAPLEXY; CHILD; DAYTIME SOMNOLENCE; DRUG DOSE INCREASE; DRUG EFFICACY; EPWORTH SLEEPINESS SCALE; FAMILY HISTORY; HUMAN; INFANT; MAINTENANCE DRUG DOSE; MALE; NIGHT SLEEP; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRESCHOOL CHILD; SCHOOL CHILD; SLEEP TIME; TODDLER;

CATAPLEXY; TODDLER; VENLAFAXINE;

CATAPLEXY; CHILD, PRESCHOOL; CYCLOHEXANOLS; FOLLOW-UP STUDIES; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84890395142     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.3284     Document Type: Article

References (5)

1. Aran A, Einen M, Lin L, et al. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010;33:1457-64.
2. Hollander E, Kaplan A, Cartwright C, Reichman D. Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. J Child Neurol 2000;15:132-5.
3. Findling R, Greenhill L, McNamara N, et al. Venlafaxine in the treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:433-45.
4. Kervela J, Castagnet S, Chiadmi F, et al. Assessment of stability in extemporaneously prepared venlafaxine solutions. Eur J Hosp Pharm 2009;15:30-2.
5. Moller L, Ostergaard J. Treatment with venlafaxine in six cases of children with narcolepsy with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol 2009;19:197-201.